Physician profile
Riley E Slate
NPI 1174113435
$1,413.04
in general payments reported to CMS, 2019-2025
14 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $125 · 2024: $640 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.35 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $358.12 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $249.56 | 2023-2024 | Camzyos, Eliquis |
| Astellas Pharma US INC | $167.85 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $132.15 | 2024-2025 | Zurzuvae |
| Janssen Pharmaceuticals, INC | $124.74 | 2022 | |
| Sumitomo Pharma America, INC. | $86.17 | 2024-2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $68.57 | 2024-2025 | Slynd |
| Millicent US INC | $53.34 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Abbvie INC. | $52.93 | 2024-2025 | |
| Coopersurgical, INC. | $34.38 | 2024 | Paragard T 380a |
| Exact Sciences Corporation | $30.45 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $25.85 | 2025 | Aptima, Thinprep 2000 Processor |
| Aspira Women'S Health INC | $15.36 | 2024 | Ova1 |
| Merck Sharp & Dohme LLC | $13.57 | 2025 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riley Slate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.